The National Institute of Neurological Disorders and Stroke (NINDS) is offering the CREATE Bio Optimization Track for Biologics grant to support the optimization of therapeutic Biotechnology Products and Biologics for disorders within NINDS mission. This grant aims to further characterize and optimize promising therapeutic agents proven through in vivo studies, leading to the development of an optimized therapeutic candidate with bioactivity, stability, manufacturability, and efficacy, suitable for entry into the CREATE Bio Development track. The closing date for applications is May 07, 2021.
Opportunity ID: 296366
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-457 |
| Funding Opportunity Title: | NINDS CREATE Bio Optimization Track for Biologics (U44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Aug 11, 2017 |
| Last Updated Date: | Apr 28, 2020 |
| Original Closing Date for Applications: | Sep 07, 2020 |
| Current Closing Date for Applications: | May 07, 2021 |
| Archive Date: | Jun 06, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) supports SBIRs in the optimization of potential therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging modalities) for disorders identified under the NINDS mission. This track supports the further characterization and optimization of therapeutic agent(s) that showed promise as evidenced by relevant, rigorous, convincing in vivo studies. Therefore, at the end of this funding period, successful projects will have delivered an optimized therapeutic candidate with demonstrated bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and should be eligible for entry into the CREATE Bio Development track. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-457.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| updated close date as per NOT-NS-20-054 | Apr 28, 2020 | |
| Aug 11, 2017 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-457 |
| Funding Opportunity Title: | NINDS CREATE Bio Optimization Track for Biologics (U44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Aug 11, 2017 |
| Last Updated Date: | Apr 28, 2020 |
| Original Closing Date for Applications: | Sep 07, 2020 |
| Current Closing Date for Applications: | May 07, 2021 |
| Archive Date: | Jun 06, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) supports SBIRs in the optimization of potential therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging modalities) for disorders identified under the NINDS mission. This track supports the further characterization and optimization of therapeutic agent(s) that showed promise as evidenced by relevant, rigorous, convincing in vivo studies. Therefore, at the end of this funding period, successful projects will have delivered an optimized therapeutic candidate with demonstrated bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and should be eligible for entry into the CREATE Bio Development track. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-457.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-457 |
| Funding Opportunity Title: | NINDS CREATE Bio Optimization Track for Biologics (U44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 11, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Sep 07, 2020 |
| Archive Date: | Oct 13, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) supports SBIRs in the optimization of potential therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging modalities) for disorders identified under the NINDS mission. This track supports the further characterization and optimization of therapeutic agent(s) that showed promise as evidenced by relevant, rigorous, convincing in vivo studies. Therefore, at the end of this funding period, successful projects will have delivered an optimized therapeutic candidate with demonstrated bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and should be eligible for entry into the CREATE Bio Development track. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-457.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00235415 | Oct 27, 2017 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260196 | Jan 13, 2018 | May 07, 2021 | View |
Package 1
Mandatory forms
296366 RR_SF424_2_0-2.0.pdf
296366 PHS398_CoverPageSupplement_4_0-4.0.pdf
296366 RR_OtherProjectInfo_1_4-1.4.pdf
296366 PerformanceSite_2_0-2.0.pdf
296366 RR_KeyPersonExpanded_2_0-2.0.pdf
296366 RR_Budget_1_4-1.4.pdf
296366 PHS398_ResearchPlan_4_0-4.0.pdf
296366 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
296366 RR_SubawardBudget30_1_4-1.4.pdf
296366 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
296366 RR_SF424_2_0-2.0.pdf
296366 PHS398_CoverPageSupplement_5_0-5.0.pdf
296366 RR_OtherProjectInfo_1_4-1.4.pdf
296366 PerformanceSite_2_0-2.0.pdf
296366 RR_KeyPersonExpanded_2_0-2.0.pdf
296366 RR_Budget_1_4-1.4.pdf
296366 PHS398_ResearchPlan_4_0-4.0.pdf
296366 SBIR_STTR_Information_1_3-1.3.pdf
296366 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
296366 RR_SubawardBudget30_1_4-1.4.pdf
296366 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
